Skip to main content

Search

By Susan Morse | 11:00 am | July 08, 2025
Unless vacated, the directive will result in preventable deaths, including the unborn and newborns under six months old, lawsuit says.
By Susan Morse | 11:26 am | July 03, 2025
The policy would have prevented PBMs from having their compensation linked to the list price of medications.
By Jeff Lagasse | 10:33 am | July 03, 2025
The company is adding new products treating a range of issues, including HIV, hypertension and behavioral health.
By Susan Morse | 11:18 am | June 30, 2025
A telehealth provision in bill makes permanent first-dollar coverage for High-Deductible Health Plan-Health Savings Accounts, says ATA.
By Jeff Lagasse | 03:36 pm | June 24, 2025
Ninety-two percent of GLP-1 prescriptions could have been filled at a lower price, study finds.
By Susan Morse | 11:16 am | June 11, 2025
Tax policy has shifted drug manufacturing to Switzerland, Ireland and Germany, says Johns Hopkins expert.
By Jeff Lagasse | 10:48 am | June 11, 2025
The pricing relationship is entirely between GoodRx and the pharmacy, with no involvement from a PBM.
By Susan Morse | 11:26 am | June 10, 2025
Committee members have conflicts of interest and have acted as a rubber stamp for vaccines, Kennedy wrote in a WSJ op-ed.
By Jeff Lagasse | 03:23 pm | June 09, 2025
More than 50M beneficiaries who manage multiple daily medications can now use their insurance for PillPack.
By Jeff Lagasse | 12:14 pm | May 27, 2025
The MAHA Commission says more rigorous clinical trials are needed for children's vaccines, while PhRMA defends current practices.